When does Roche report earnings and how will it affect ROG.SW stock

Roche reports on **29 Jan 2026**. Earnings will affect ROG.SW stock through EPS progress, guidance, and commentary on pricing and production. Expect higher intraday volatility and a focus on Genentech updates that may shift investor sentiment.

What are the key valuation metrics to watch for ROG.SW stock

Watch **PE 29.70**, **price-to-book 9.74**, and **free cash flow per share CHF15.68**. These metrics signal a premium valuation for ROG.SW stock and will shape market reaction if growth guidance misses expectations.

What is Meyka AI’s grade for ROG.SW stock and what does it mean

Meyka AI rates ROG.SW with a score out of 100: **69.21 | Grade: B | Suggestion: HOLD**. The grade balances cash flow strength, sector context, and valuation. It is informational and not investment advice.

How should investors approach ROG.SW stock before earnings

Approach ROG.SW stock with defined risk limits and position sizing. Use options or stop limits for earnings risk. Focus on guidance cues and consider the dividend yield **2.79%** if holding through volatility.

CH Stocks

ROG.SW Roche Holding AG (SIX) Jan 26 2026 Pre-Mkt: Earnings in focus, CHF347.90

ByHuzaifa Zahoor January 26, 2026January 26, 2026

The ROG.SW stock opens pre-market with Roche Holding AG priced at CHF347.90 on the SIX exchange in Switzerland as investors eye the earnings release due on 29 Jan 2026. Volume is 876,097 shares and the 50-day average sits at CHF322.19. Early moves will hinge on guidance and Genentech manufacturing updates after recent site investments and approvals.